UniProtKB/SwissProt variant VAR

Variant information

Variant position:

433

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

LP/P [Disclaimer]

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Serine (S) to Glycine (G) at position 433 (S433G, p.Ser433Gly).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from small size and polar (S) to glycine (G)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

0

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Variant description:

In PHA2D; decreased interaction with WNK4.

Any additional useful information about the variant.

Sequence information

Variant position:

433

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

587

The length of the canonical sequence.

Location on the sequence:

AYSYKTNEWFFVAPMNTRRS S VGVGVVEGKLYAVGGYDGAS

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         AYSYKTNEWFFVAPMNTRRSSVGVGVVEGKLYAVGGYDGAS

Mouse                         AYSYKTNEWFFVAPMNTRRSSVGVGVVEGKLYAVGGYDGAS

Rat                           AYSYKTNEWFFVAPMNTRRSSVGVGVVEGKLYAVGGYDGAS

Bovine                        AYSYKTNEWFFVAPMNTRRSSVGVGVVEGKLYAVGGYDGAS

Zebrafish                     AYNPKANEWMFVAPMNTRRSSVGVGVVDGKLYAVGGYDGAS

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 587	Kelch-like protein 3
Repeat	396 – 441	Kelch 3
Modified residue	433 – 433	Phosphoserine; by PKA
Mutagenesis	433 – 433	S -> ED. Phosphomimetic mutant that shows decreased interaction with WNK4.

Literature citations

Impaired degradation of WNK by Akt and PKA phosphorylation of KLHL3.
Yoshizaki Y.; Mori Y.; Tsuzaki Y.; Mori T.; Nomura N.; Wakabayashi M.; Takahashi D.; Zeniya M.; Kikuchi E.; Araki Y.; Ando F.; Isobe K.; Nishida H.; Ohta A.; Susa K.; Inoue Y.; Chiga M.; Rai T.; Sasaki S.; Uchida S.; Sohara E.;
Biochem. Biophys. Res. Commun. 467:229-234(2015)
Cited for: PHOSPHORYLATION AT SER-10; THR-295; THR-375; SER-376 AND SER-433; INTERACTION WITH WNK4; CHARACTERIZATION OF VARIANT PHA2D GLY-433; MUTAGENESIS OF SER-433;

KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron.
Louis-Dit-Picard H.; Barc J.; Trujillano D.; Miserey-Lenkei S.; Bouatia-Naji N.; Pylypenko O.; Beaurain G.; Bonnefond A.; Sand O.; Simian C.; Vidal-Petiot E.; Soukaseum C.; Mandet C.; Broux F.; Chabre O.; Delahousse M.; Esnault V.; Fiquet B.; Houillier P.; Bagnis C.I.; Koenig J.; Konrad M.; Landais P.; Mourani C.; Niaudet P.; Probst V.; Thauvin C.; Unwin R.J.; Soroka S.D.; Ehret G.; Ossowski S.; Caulfield M.; Bruneval P.; Estivill X.; Froguel P.; Hadchouel J.; Schott J.J.; Jeunemaitre X.;
Nat. Genet. 44:456-460(2012)
Cited for: VARIANTS PHA2D GLY-228; MET-361; TRP-362; TRP-384; VAL-398; LEU-410; LEU-426; ASN-432; GLY-433; VAL-500; HIS-528; CYS-528 AND LYS-529; FUNCTION; SUBCELLULAR LOCATION; TISSUE SPECIFICITY; INTERACTION WITH SLC12A3;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9UH77: Variant p.Ser433Gly